The city of Baltimore, Maryland, currently has 13 active clinical trials seeking participants for Alzheimer's Disease research studies.
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
Recruiting
The Anti-Aβ mAb CED Study is a prospective, longitudinal coverage with evidence development (CED) study using clinical data, patient assessments, and administrative claims data of the Medicare population, conducted in accordance to the National Coverage Determination (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (AD).
Gender:
ALL
Ages:
All
Trial Updated:
09/21/2023
Locations: Centers for Medicare and Medicaid Services, Baltimore, Maryland
Conditions: Mild Alzheimer's Disease, Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease